Citadel Advisors’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.3K Sell
10,100
-15,100
-60% -$157K ﹤0.01% 12110
2025
Q4
$299K Buy
25,200
+1,500
+6% +$19.8K ﹤0.01% 10161
2025
Q3
$334K Buy
23,700
+12,200
+106% +$154K ﹤0.01% 10114
2025
Q2
$111K Buy
11,500
+100
+0.9% +$1.13K ﹤0.01% 11250
2025
Q1
$145K Buy
11,400
+3,500
+44% +$56K ﹤0.01% 10923
2024
Q4
$163K Sell
7,900
-12,600
-61% -$206K ﹤0.01% 10757
2024
Q3
$289K Sell
20,500
-24,400
-54% -$355K ﹤0.01% 9409
2024
Q2
$561K Buy
44,900
+21,400
+91% +$260K ﹤0.01% 7826
2024
Q1
$312K Sell
23,500
-1,280
-5% -$19.8K ﹤0.01% 9375
2023
Q4
$469K Sell
24,780
-780
-3% -$12.8K ﹤0.01% 8254
2023
Q3
$385K Sell
25,560
-4,820
-16% -$90.4K ﹤0.01% 8640
2023
Q2
$656K Buy
30,380
+4,840
+19% +$132K ﹤0.01% 7340
2023
Q1
$718K Buy
25,540
+5,360
+27% +$152K ﹤0.01% 7500
2022
Q4
$510K Buy
20,180
+3,480
+21% +$106K ﹤0.01% 8191
2022
Q3
$481K Sell
16,700
-260
-2% -$7.7K ﹤0.01% 8537
2022
Q2
$429K Buy
+16,960
New +$489K ﹤0.01% 8993

Other funds holding EMBC

Citadel Advisors's EMBC Position: Q1 2026 in Review

Citadel Advisors increased its Embecta (EMBC) stake by 78% in Q1 2026, buying an estimated $1.78M and bringing the position to 391,819 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #4981.

Citadel Advisors first reported a position in EMBC in Q3 2022 and has held it in 15 quarters since. The position peaked at $10.8M in Q4 2023. 339 funds tracked by Wall St. Rank hold EMBC as of Q1 2026.

  • Citadel Advisors held 391,819 shares of Embecta worth $3.46M as of Q1 2026.
  • Citadel Advisors bought 171,122 Embecta shares in Q1 2026, an estimated $1.78M.
  • Embecta made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4981 holding.
  • Citadel Advisors first reported a position in Embecta in Q3 2022 and has held it in 15 quarters since.
  • Citadel Advisors's Embecta position peaked at $10.8M in Q4 2023.
  • 339 funds tracked by Wall St. Rank held Embecta as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.